Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial.

Mulvagh SL, Inzucchi SE, Marx N, Poulter NR, Deanfield JE, Pop-Busui R, Emerson SS, Mann JFE, Engelmann MDM, Hovingh GK, Mandavya K, Davicevic-Elez Z, Jeppesen OK, Lorenzatti A, Oguz A, Mankovsky B, Deerochanawong C, Gorgojo-Martinez JJ, Ji L, Bain SC, McGuire DK, Buse JB, SOUL Study Group

Open source

DOI: 10.1001/jamacardio.2026.0245
Published: 2026 May 1
Container: JAMA cardiology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamacardio.2026.0245,
  title = {Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial.},
  author = {Mulvagh SL and Inzucchi SE and Marx N and Poulter NR and Deanfield JE and Pop-Busui R and Emerson SS and Mann JFE and Engelmann MDM and Hovingh GK and Mandavya K and Davicevic-Elez Z and Jeppesen OK and Lorenzatti A and Oguz A and Mankovsky B and Deerochanawong C and Gorgojo-Martinez JJ and Ji L and Bain SC and McGuire DK and Buse JB and SOUL Study Group},
  year = {2026},
  journal = {JAMA cardiology},
  doi = {10.1001/jamacardio.2026.0245},
  url = {https://doi.org/10.1001/jamacardio.2026.0245}
}

RIS

TY  - JOUR
TI  - Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial.
AU  - Mulvagh SL
AU  - Inzucchi SE
AU  - Marx N
AU  - Poulter NR
AU  - Deanfield JE
AU  - Pop-Busui R
AU  - Emerson SS
AU  - Mann JFE
AU  - Engelmann MDM
AU  - Hovingh GK
AU  - Mandavya K
AU  - Davicevic-Elez Z
AU  - Jeppesen OK
AU  - Lorenzatti A
AU  - Oguz A
AU  - Mankovsky B
AU  - Deerochanawong C
AU  - Gorgojo-Martinez JJ
AU  - Ji L
AU  - Bain SC
AU  - McGuire DK
AU  - Buse JB
AU  - SOUL Study Group
PY  - 2026
JO  - JAMA cardiology
DO  - 10.1001/jamacardio.2026.0245
UR  - https://doi.org/10.1001/jamacardio.2026.0245
ER  -

APA

SL, M., SE, I., N, M., NR, P., JE, D., R, P., SS, E., JFE, M., MDM, E., GK, H., K, M., Z, D., OK, J., A, L., A, O., B, M., C, D., JJ, G., L, J., SC, B., DK, M., JB, B., & Group, S. S. (2026). Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial.. JAMA cardiology. https://doi.org/10.1001/jamacardio.2026.0245

Source records

pubmed · retrieved 2026-09-27T06:45:03.975Z